Last reviewed · How we verify
Standard SPF 4 Sunscreen
Protects skin from the sun's ultraviolet (UV) rays.
Protects skin from the sun's ultraviolet (UV) rays. Used for Prevention of sunburn.
At a glance
| Generic name | Standard SPF 4 Sunscreen |
|---|---|
| Sponsor | Bayer |
| Drug class | Sunscreen |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Standard SPF 4 Sunscreen works by creating a physical barrier on the skin's surface that absorbs or reflects UV radiation, preventing it from penetrating the skin and causing damage.
Approved indications
- Prevention of sunburn
Common side effects
- Skin irritation
Key clinical trials
- Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics (NA)
- Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis (PHASE1)
- Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars (PHASE2, PHASE3)
- A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations (NA)
- Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED) (PHASE3)
- Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard SPF 4 Sunscreen CI brief — competitive landscape report
- Standard SPF 4 Sunscreen updates RSS · CI watch RSS
- Bayer portfolio CI